Jornal Vascular Brasileiro
https://jvascbras.org/article/doi/10.1590/jvb.2014.042
Jornal Vascular Brasileiro
Review Article

Periodontal disease and atherosclerosis

Doença periodontal e aterosclerose

Jeferson Freitas Toregeani; Carlos Augusto Nassar; Krischina Aparecida Mendes Toregeani; Patrícia Oehlmeyer Nassar

Downloads: 0
Views: 809

Abstract

Atherosclerotic disease (AD) is one of the most important causes of morbidity and mortality in the world. It expresses inflammatory markers such as C-reactive protein (CRP) and can provoke arterial wall thickening, which can be evaluated using Doppler ultrasound. Risk factors associated with AD include diabetes mellitus, systemic arterial hypertension, dyslipidemia and smoking. More recently, periodontal disease (PD) has been identified as a factor related to AD. Periodontal disease has a high prevalence in the global population and the inflammatory process and bacterial activity at the periodontium appear to increase the risk of AD. Encouraging good oral hygiene can reduce expression of inflammatory markers of AD. A review of literature on PD, AD and inflammatory markers and the interrelationships between the two diseases was conducted using data published in articles indexed on the PUBMED, SCIELO and BIREME databases.

Keywords

periodontal disease, atherosclerosis, carotid intima-media thickness

Resumo

A doença aterosclerótica (DA) constitui uma das principais causas de morbimortalidade no mundo. A sua expressão laboral pode ser através de marcadores inflamatórios, como a proteína C reativa (PCR) e/ou o espessamento da parede arterial, que pode ser analisado pela ultrassonografia com Doppler colorido. Os fatores de risco associados à DA são o diabetes mellitus, a hipertensão arterial sistêmica, a dislipidemia e o tabagismo. Mais recentemente, a doença periodontal (DP), que tem uma elevada prevalência na população mundial, tem sido considerada um fator relacionado ao desenvolvimento da DA, em que o processo inflamatório e a atividade bacteriana no periodonto parecem aumentar o risco para a DA. A motivação da higiene oral pode diminuir a expressão dos marcadores inflamatórios da DA. Com base em dados publicados em revistas eletrônicas e indexados pelos mecanismos de busca PUBMED, SCIELO e BIREME, foi realizada uma revisão de literatura sobre a DP e a DA, além dos marcadores inflamatórios expressos em ambas as doenças e suas possíveis inter-relações.

Palavras-chave

doença periodontal, aterosclerose, espessura íntima-média carotídea

References

Dumitrescu AL. Influence of periodontal disease on cardiovascular diseases. Rom J Intern Med. 2005;43(1-2):9-21.

Bongard V, Cambou JP, Lezorovcz A. Comparison of cardiovascular risk factors and drug use in 14,544 French patients with a history of myocardial infarction, ischaemic stroke and/or peripheral arterial disease. Eur J Cardiovasc Prev Rehabil. 2004;11(5):394-402.

Balan H. Do cardio-vascular and periodontal diseases have a close, causal relationship?. Rom J Intern Med. 2010;48(2):121-9.

NCD Brazil profiles. 2011.

World Health Statistics. 2013.

Fischer RG. Periodontia: a atuação clínica baseada em evidências científicas. Doença periodontal e doenças cardiovasculares. 2005:285-9.

Schmidt MI, Duncan BB, Azevedo e Silva G. Chronic noncommunicable diseases in Brazil: burden and current challenges. Lancet. 2011;377(9781):1949-61.

Paizan ML, Martin JFV. Association between periodontal disease, cardiovascular disease and hypertension. Rev Bras Hipertens. 2009;16(3):183-5.

Almeida CSL, Dias LZS. The importance of inflammatory citokynes in the causal relationship between periodontal and cardiovascular diseases. Rev ABO Nac. 2008;16(5):294-8.

Jorge PAR. Endotélio, lípides e aterosclerose. Arq Bras Cardiol. 1997;68(2):129-34.

Ramírez JH, Arce RM, Contreras A. Periodontal treatment effects on endothelial function and cardiovascular disease biomarkers in subjects with chronic periodontitis: protocol for a randomized clinical trial. Trials. 2011;12(1):46.

Napoli C, Glass CK, Witztum JL, Deutsch R, D'Armiento FP, Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet. 1999;354(9186):1234-41.

Teixeira J, Morado Pinho M. Association between periodontitis and stroke (CVA). Rev Port Estomatol Med Dent Cir Maxilofac. 2011;52(2):115-21.

Nguyen TT, Liao Y, Gildengorin G, Tsoh J, Bui-Tong N, McPhee SJ. Cardiovascular risk factors and knowledge of symptoms among Vietnamese Americans. J Gen Intern Med. 2009;24(2):238-43.

Hara T, Takamura N, Akashi S. Evaluation of clinical markers of atherosclerosis in young and elderly Japanese adults. Clin Chem Lab Med. 2006;44(7):824-9.

Kanoh Y. Biochemical markers and physiological tests of atherosclerosis—changes and usefulness of markers in anti-atherosclerotic therapy. Rinsho Byori. 2011;59(1):80-8.

Thompson D, Pepys MB, Wood SP. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure. 1999;7(2):169-77.

Tillett WS, Francis T. Serological Reactions in Pneumonia with a Non-Protein Somatic Fraction of Pneumococcus. J Exp Med. 1930;52(4):561-71.

Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448-54.

Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805-12.

Torzewski M, Rist C, Mortensen RF. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol. 2000;20(9):2094-9.

Volp AC, Alfenas RC, Costa NM, Minim VP, Stringueta PC, Bressan J. Inflammation biomarkers capacity in predicting the metabolic syndrome. Arq Bras Endocrinol Metabol. 2008;52(3):537-49.

Torzewski M, Bhakdi S. Complement and atherosclerosis-united to the point of no return?. Clin Biochem. 2013;46(1-2):20-5.

Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today. 1994;15(2):81-8.

Biasucci LM, Vitelli A, Liuzzo G. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996;94(5):874-7.

Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286(3):327-34.

Rudd JH, Myers KS, Sanz J, Fayad ZA. Multimodality imaging of atherosclerosis (magnetic resonance imaging/computed tomography/positron emission tomography-computed tomography). Top Magn Reson Imaging. 2007;18(5):379-88.

Casella IB, Presti C, Porta RM, Sabbag CR, Bosch MA, Yamazaki Y. A practical protocol to measure common carotid artery intimamedia thickness. Clinics (São Paulo). 2008;63(4):515-20.

de Korte CL, Hansen HH, van der Steen AF. Vascular ultrasound for atherosclerosis imaging. Interface Focus. 2011;1(4):565-75.

Tola M, Yurdakul M, Cumhur T. Combined use of color duplex ultrasonography and B-flow imaging for evaluation of patients with carotid artery stenosis. AJNR Am J Neuroradiol. 2004;25(10):1856-60.

Discover the extraordinary potential of RF-data Technology, the unexplored side of ultrasound. 2009.

Ciccone MM, Scicchitano P, Zito A. Correlation between coronary artery disease severity, left ventricular mass index and carotid intima media thickness, assessed by radiofrequency. Cardiovasc Ultrasound. 2011;9(1):32.

Schreuder FH, Graf M, Hameleers JM, Mess WH, Hoeks AP. Measurement of common carotid artery intima-media thickness in clinical practice: comparison of B-mode and RF-based technique. Ultraschall Med. 2009;30(5):459-65.

Smith Jr SC, Amsterdam E, Balady GJ. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: tests for silent and inducible ischemia: Writing Group II. Circulation. 2000;101(1):E12-6.

Touboul PJ, Hennerici MG, Meairs S. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the A dvisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis. 2007;23(1):75-80.

Roman MJ, Naqvi TZ, Gardin JM, Gerhard-Herman M, Jaff M, Mohler E. American society of echocardiography report. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology. Vasc Med. 2006;11(3):201-11.

Gerhard-Herman M, Gardin JM, Jaff M, Mohler E, Roman M, Naqvi TZ. Guidelines for noninvasive vascular laboratory testing: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology. Vasc Med. 2006;11(3):183-200.

Nanci A, Bosshardt DD. Structure of periodontal tissues in health and disease. Periodontol. 2000;40:11-28.

Buhlin K, Gustafsson A, Pockley AG, Frostegård J, Klinge B. Risk factors for cardiovascular disease in patients with periodontitis. Eur Heart J. 2003;24(23):2099-107.

de Oliveira C, Watt R, Hamer M. Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey. BMJ. 2010;340(1):c2451.

Chen YW, Umeda M, Nagasawa T. Periodontitis may increase the risk of peripheral arterial disease. Eur J Vasc Endovasc Surg. 2008;35(2):153-8.

Iacopino AM, Cutler CW. Pathophysiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids. J Periodontol. 2000;71(8):1375-84.

Mattila KJ, Nieminen MS, Valtonen VV. Association between dental health and acute myocardial infarction. BMJ. 1989;298(6676):779-81.

Newman MG, Takei HH, Klokkevold PR, Carranza FA. Carranza periodontia clínica. 2006.

Powell CA, Bannister SR, Mackey SA, Maller SC, McDonnell HT, Deas DE. Periodontal wound healing with and without plateletrich plasma: histologic observations and assessment of flap tensile strength. J Periodontol. 2009;80(6):985-92.

Bailey MT, Kinsey SG, Padgett DA, Sheridan JF, Leblebicioglu B. Social stress enhances IL-1beta and TNF-alpha production by Porphyromonas gingivalis lipopolysaccharide-stimulated CD11b+ cells. Physiol Behav. 2009;98(3):351-8.

Hilgert JB, Hugo FN, Bandeira DR, Bozzetti MC. Stress, cortisol, and periodontitis in a population aged 50 years and over. J Dent Res. 2006;85(4):324-8.

Deinzer R, Förster P, Fuck L, Herforth A, Stiller-Winkler R, Idel H. Increase of crevicular interleukin 1beta under academic stress at experimental gingivitis sites and at sites of perfect oral hygiene. J Clin Periodontol. 1999;26(1):1-8.

Friedewald VE, Kornman KS, Beck JD. The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease. Am J Cardiol. 2009;104(1):59-68.

Beck JD, Eke P, Heiss G. Periodontal disease and coronary heart disease: a reappraisal of the exposure. Circulation. 2005;112(1):19-24.

Seymour RA, Steele JG. Is there a link between periodontal disease and coronary heart disease?. Br Dent J. 1998;184(1):33-8.

Mattila K, Vesanen M, Valtonen V. Effect of treating periodontitis on C-reactive protein levels: a pilot study. BMC Infect Dis. 2002;2(1):30.

Ge S, Wu YF, Liu TJ, Meng S, Zhao L. Study of the correlation between moderately and severely chronic periodontitis and coronary heart disease. Hua Xi Kou Qiang Yi Xue Za Zhi. 2008;26(3):262-6.

Ge S, Wu YF, Liu TJ, He QM, Zhao L, Meng S. Correlation between levels of fibrinogen, beta455 g/A fibrinogen gene polymorphism and chronic periodontitis. Zhonghua Kou Qiang Yi Xue Za Zhi. 2008;43(2):87-91.

Tonetti MS, Van Dyke TE. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol. 2013;40(^sSuppl 14):S24-9.

DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary heart disease and mortality. BMJ. 1993;306(6879):688-91.

Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol. 1996;67(10^sSuppl):1123-37.

Janket SJ, Baird AE, Chuang SK, Jones JA. Meta-analysis of periodontal disease and risk of coronary heart disease and stroke. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95(5):559-69.

Thomopoulos C, Tsioufis C, Soldatos N, Kasiakogias A, Stefanadis C. Periodontitis and coronary artery disease: a questioned association between periodontal and vascular plaques. Am J Cardiovasc Dis. 2011;1(1):76-83.

Hung HC, Willett W, Merchant A, Rosner BA, Ascherio A, Joshipura KJ. Oral health and peripheral arterial disease. Circulation. 2003;107(8):1152-7.

Lane JS, Vittinghoff E, Lane KT, Hiramoto JS, Messina LM. Risk factors for premature peripheral vascular disease: results for the National Health and Nutritional Survey, 1999-2002. J Vasc Surg. 2006;44(2):319-24.

Genco R, Offenbacher S, Beck J. Periodontal disease and cardiovascular disease: epidemiology and possible mechanisms. J Am Dent Assoc. 2002;133(1^sSuppl):14S-22S.

Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)"> Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)">
5ddd81120e882539381da3e9 jvb Articles
Links & Downloads

J Vasc Bras

Share this page
Page Sections